Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2016

Feb 1, 2016

5262_dirs_2016-02-01_4ec4a57c-f6b2-4da3-bec0-b5768b51e8f9.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6526N

GlaxoSmithKline PLC

01 February 2016

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

In accordance with DTR 3.1.4R(1)(a) I give details of changes in the interests of the following Person Discharging Managerial Responsibilities ('PDMR'), who acquired Ordinary Shares ('Shares') in GlaxoSmithKline plc ('GSK') at a price of 1367.57 pence per Share, following the re-investment of dividends paid on 14 January 2016, on Shares held in the GSK 2009 Deferred Annual Bonus Plan Post-Tax.

PDMR Number of Ordinary Shares acquired under the personal contribution element of the plan Number of Ordinary Shares acquired under the matching element of the plan

(GSK contribution)
Ms C Thomas 37.982 38.185

GSK was advised of this allocation on 28 January 2016.

V A Whyte

Company Secretary

1 February 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSLFLFBQLFEBBL